Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaro Suzuki

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|January 9, 2019
[Long QT Syndrome Induced by Antidepressants]Yutaro Suzuki
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|January 9, 2019
[The Safety of Using Long-acting Injections : From an Opposing Position-Is It Better to Administer Long-acting Injections?]Yutaro Suzuki
International Journal of Hematology|October 30, 2022
Chronic cold agglutinin disease after a third COVID-19 mRNA vaccinationYutaro Suzuki, Teruo Shiba
General Hospital Psychiatry|July 27, 2012
Prolongation of idiopathic thrombocytopenic purpura associated with paroxetine administrationShin Ono, Yutaro Suzuki, Toshiyuki Someya
Psychiatry and Clinical Neurosciences|February 23, 2012
Delirium associated with duloxetine in a depressed patient with Alzheimer's dementiaYutaro Suzuki, Mami Saito, Toshiyuki Someya
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 6, 2005
Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patientsYutaro Suzuki, Kazushi Sawamura, Toshiyuki Someya
Psychiatry and Clinical Neurosciences|September 5, 2014
QT prolongation associated with memantine in Alzheimer's diseaseHiromi Takehara, Yutaro Suzuki, Toshiyuki Someya
European Journal of Clinical Pharmacology|September 7, 2004
Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetineKazushi Sawamura, Yutaro Suzuki, Toshiyuki Someya
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|August 17, 2006
[Molecular pharmacogenetic study on antipsychotic-drug therapy responders with depression or schizophrenia]Yutaro Suzuki, Hitoshi Sawamura, Toshiyuki Someya
Current Atherosclerosis Reports|December 11, 2012
Lipid effects of psychiatric medicationsJunzo Watanabe, Yutaro Suzuki, Toshiyuki Someya
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|January 9, 2019
[Long QT Syndrome Induced by Antidepressants]Yutaro Suzuki
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|January 9, 2019
[The Safety of Using Long-acting Injections : From an Opposing Position-Is It Better to Administer Long-acting Injections?]Yutaro Suzuki
International Journal of Hematology|October 30, 2022
Chronic cold agglutinin disease after a third COVID-19 mRNA vaccinationYutaro Suzuki, Teruo Shiba
General Hospital Psychiatry|July 27, 2012
Prolongation of idiopathic thrombocytopenic purpura associated with paroxetine administrationShin Ono, Yutaro Suzuki, Toshiyuki Someya
Psychiatry and Clinical Neurosciences|February 23, 2012
Delirium associated with duloxetine in a depressed patient with Alzheimer's dementiaYutaro Suzuki, Mami Saito, Toshiyuki Someya
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 6, 2005
Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patientsYutaro Suzuki, Kazushi Sawamura, Toshiyuki Someya
Psychiatry and Clinical Neurosciences|September 5, 2014
QT prolongation associated with memantine in Alzheimer's diseaseHiromi Takehara, Yutaro Suzuki, Toshiyuki Someya
European Journal of Clinical Pharmacology|September 7, 2004
Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetineKazushi Sawamura, Yutaro Suzuki, Toshiyuki Someya
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|August 17, 2006
[Molecular pharmacogenetic study on antipsychotic-drug therapy responders with depression or schizophrenia]Yutaro Suzuki, Hitoshi Sawamura, Toshiyuki Someya
Current Atherosclerosis Reports|December 11, 2012
Lipid effects of psychiatric medicationsJunzo Watanabe, Yutaro Suzuki, Toshiyuki Someya
Pageof 12